The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway
Abstract
The coagulant and inflammatory exacerbation in sepsis is counterbalanced by the protective protein C (PC) pathway. Activated PC (APC) was shown to use the endothelial cell PC receptor (EPCR) as a coreceptor for cleavage of protease activated receptor 1 (PAR1) on endothelial cells. Gene profiling demonstrated that PAR1 signaling could account for all APC-induced protective genes, including the immunomodulatory monocyte chemoattractant protein-1 (MCP-1), which was selectively induced by activation of PAR1, but not PAR2. Thus, the prototypical thrombin receptor is the target for EPCR-dependent APC signaling, suggesting a role for this receptor cascade in protection from sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Thrombin signalling and protease-activated receptors
Coughlin, S. R. (2000) · Nature · doi:10.1038/35025229 · Cited by 2,482
Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409
Feedback Inhibition of Macrophage Tumor Necrosis Factor-α Production by Tristetraprolin
Carballo, E., Lai, W. S., & Blackshear, P. J. (1998) · Science · doi:10.1126/science.281.5379.1001 · Cited by 1,161
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
Taylor, F. B., Chang, A., Esmon, C. T., D'Angelo, A., Vigano-D'Angelo, S., & Blick, K. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112902 · Cited by 821
Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis
Faust, S. N., Levin, M., Harrison, O. B., Goldin, R. D., Lockhart, M. S., Kondaveeti, S., Laszik, Z., Esmon, C. T., & Heyderman, R. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450603 · Cited by 690
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
Camerer, E., Huang, W., & Coughlin, S. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5255 · Cited by 675
Joyce, D. E., Gelbert, L., Ciaccia, A., DeHoff, B., & Grinnell, B. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100017200 · Cited by 648
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
Creasey, A. A., Chang, A. C., Feigen, L., Wün, T. C., Taylor, F. B., & Hinshaw, L. B. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116529 · Cited by 547
Esmon, C. T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615164 · Cited by 377
Cited by
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
“These include neutralizers of tumour-necrosis factor (TNF); blockers of leukotriene receptors; inhibitors of cyclooxygenase (COX)-2, leukotriene synthetase and 3-hydroxy-3-methylglutaryl coenzyme A reductase; and agonism at protease-activated receptor 1 by activated protein C (ref”
BackgroundExtracellular histones are major mediators of death in sepsis
Xu, J., Zhang, X., Pelayo, R., Monestier, M., Ammollo, C. T., Semeraro, F., Taylor, F. B., Esmon, N. L., Lupu, F., & Esmon, C. T. (2009) · Nature Medicine · doi:10.1038/nm.2053 · Cited by 1,539
Harmful molecular mechanisms in sepsis
Rittirsch, D., Flierl, M. A., & Ward, P. A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2402 · Cited by 1,202
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Aird, W. C. (2003) · Blood · doi:10.1182/blood-2002-06-1887 · Cited by 1,131
Protease-Activated Receptors: Contribution to Physiology and Disease
OSSOVSKAYA, V. S., & BUNNETT, N. W. (2004) · Physiological Reviews · doi:10.1152/physrev.00028.2003 · Cited by 1,078
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
COUGHLIN, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01377.x · Cited by 1,035
The interactions between inflammation and coagulation
Esmon, C. T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05753.x · Cited by 1,003
Levi, M., & van der Poll, T. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c98d21 · Cited by 984
Bidirectional Relation Between Inflammation and Coagulation
Levi, M., van der Poll, T., & Büller, H. R. (2004) · Circulation · doi:10.1161/01.cir.0000131660.51520.9a · Cited by 941
Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., & Kuliopulos, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.018 · Cited by 838
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
The cytoprotective protein C pathway
Mosnier, L. O., Zlokovic, B. V., & Griffin, J. H. (2007) · Blood · doi:10.1182/blood-2006-09-003004 · Cited by 754
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
Bozza, F. A., Salluh, J. I., Japiassu, A. M., Soares, M., Assis, E. F., Gomes, R. N., Bozza, M. T., Castro-Faria-Neto, H. C., & Bozza, P. T. (2007) · Critical Care · doi:10.1186/cc5783 · Cited by 740
Esmon, C. T. (2003) · Chest · doi:10.1378/chest.124.3_suppl.26s · Cited by 719
Inflammation, endothelium, and coagulation in sepsis
Schouten, M., Wiersinga, W. J., Levi, M., & van der Poll, T. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607373 · Cited by 629
Riedemann, N. C., Guo, R., & Ward, P. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19523 · Cited by 624
The TREM receptor family and signal integration
Klesney-Tait, J., Turnbull, I. R., & Colonna, M. (2006) · Nature Immunology · doi:10.1038/ni1411 · Cited by 589
Cross Talk Pathways Between Coagulation and Inflammation
Foley, J. H., & Conway, E. M. (2016) · Circulation Research · doi:10.1161/circresaha.116.306853 · Cited by 589
Cheng, T., Liu, D., Griffin, J. H., Fernández, J. A., Castellino, F., Rosen, E. D., Fukudome, K., & Zlokovic, B. V. (2003) · Nature Medicine · doi:10.1038/nm826 · Cited by 560
The multifaceted role of fibrinogen in tissue injury and inflammation
Luyendyk, J. P., Schoenecker, J. G., & Flick, M. J. (2019) · Blood · doi:10.1182/blood-2018-07-818211 · Cited by 555
Abeyama, K., Stern, D. M., Ito, Y., Kawahara, K.-I., Yoshimoto, Y., Tanaka, M., Uchimura, T., Ida, N., Yamazaki, Y., Yamada, S., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522782 · Cited by 547
Steinhoff, M., Buddenkotte, J., Shpacovitch, V., Rattenholl, A., Moormann, C., Vergnolle, N., Luger, T. A., & Hollenberg, M. D. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0025 · Cited by 501
Novel mechanisms and functions of complement
Hajishengallis, G., Reis, E. S., Mastellos, D. C., Ricklin, D., & Lambris, J. D. (2017) · Nature Immunology · doi:10.1038/ni.3858 · Cited by 488
Feistritzer, C., & Riewald, M. (2005) · Blood · doi:10.1182/blood-2004-10-3985 · Cited by 475
Self-citationEsmon, C. T. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00261.x · Cited by 442
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club
Wong, F., Bernardi, M., Balk, R., Christman, B., Moreau, R., Garcia-Tsao, G., Patch, D., Soriano, G., Hoefs, J., & Navasa, M. (2005) · Gut · doi:10.1136/gut.2004.038679 · Cited by 392
Isermann, B., Vinnikov, I. A., Madhusudhan, T., Herzog, S., Kashif, M., Blautzik, J., Corat, M. A. F., Zeier, M., Blessing, E., Oh, J., et al. (2007) · Nature Medicine · doi:10.1038/nm1667 · Cited by 385
Molecular mechanisms of endothelial hyperpermeability: implications in inflammation
Kumar, P., Shen, Q., Pivetti, C. D., Lee, E. S., Wu, M. H., & Yuan, S. Y. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001112 · Cited by 380
Heuberger, D. M., & Schuepbach, R. A. (2019) · Thrombosis Journal · doi:10.1186/s12959-019-0194-8 · Cited by 371
Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation
de Wouwer, M. V., Collen, D., & Conway, E. M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000134298.25489.92 · Cited by 369
Structure, function and pathophysiology of protease activated receptors
Adams, M. N., Ramachandran, R., Yau, M.-K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., & Hooper, J. D. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.003 · Cited by 370
Dahlbäck, B., & Villoutreix, B. O. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168421.13467.82 · Cited by 358
Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement
Finigan, J. H., Dudek, S. M., Singleton, P. A., Chiang, E. T., Jacobson, J. R., Camp, S. M., Ye, S. Q., & Garcia, J. G. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412427200 · Cited by 354
Endothelial barrier dysfunction in septic shock
Opal, S. M., & van der Poll, T. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12331 · Cited by 353
Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer
Borgoño, C. A., Michael, I. P., & Diamandis, E. P. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.257.2.5 · Cited by 339
Two-Way Interactions Between Inflammation and Coagulation
Levi, M., & van der Poll, T. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.07.004 · Cited by 334
Balazs, A. B., Fabian, A. J., Esmon, C. T., & Mulligan, R. C. (2006) · Blood · doi:10.1182/blood-2005-06-2249 · Cited by 328
Inhibition of tissue factor signaling suppresses tumor growth
Versteeg, H. H., Schaffner, F., Kerver, M., Petersen, H. H., Ahamed, J., Felding-Habermann, B., Takada, Y., Mueller, B. M., & Ruf, W. (2008) · Blood · doi:10.1182/blood-2007-07-101048 · Cited by 327
Self-citationCrosstalk between inflammation and thrombosis
Esmon, C. T. (2004) · Maturitas · doi:10.1016/j.maturitas.2003.10.015 · Cited by 325
Broken Barriers: A New Take on Sepsis Pathogenesis
Goldenberg, N. M., Steinberg, B. E., Slutsky, A. S., & Lee, W. L. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002011 · Cited by 324
Thrombomodulin and its role in inflammation
Conway, E. M. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0282-8 · Cited by 322
Targeting proteinase-activated receptors: therapeutic potential and challenges
Ramachandran, R., Noorbakhsh, F., DeFea, K., & Hollenberg, M. D. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3615 · Cited by 312
The impact of the inflammatory response on coagulation
Esmon, C. T. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.028 · Cited by 311
Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia
Pawlinski, R., Pedersen, B., Schabbauer, G., Tencati, M., Holscher, T., Boisvert, W., Andrade-Gordon, P., Frank, R. D., & Mackman, N. (2004) · Blood · doi:10.1182/blood-2003-09-3051 · Cited by 308
Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C
Kerschen, E. J., Fernandez, J. A., Cooley, B. C., Yang, X. V., Sood, R., Mosnier, L. O., Castellino, F. J., Mackman, N., Griffin, J. H., & Weiler, H. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070404 · Cited by 305
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more
Ramachandran, R., & Hollenberg, M. D. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707507 · Cited by 305
The anticoagulant protein C pathway
Dahlbäck, B., & Villoutreix, B. O. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.001 · Cited by 300
Signal transduction by protease‐activated receptors
Soh, U. J., Dores, M. R., Chen, B., & Trejo, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00705.x · Cited by 294
Protease-activated receptor 2 signaling in inflammation
Rothmeier, A. S., & Ruf, W. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0289-1 · Cited by 289
Self-citationProtease-Activated Receptors in Cardiovascular Diseases
Leger, A. J., Covic, L., & Kuliopulos, A. (2006) · Circulation · doi:10.1161/circulationaha.105.574830 · Cited by 289
Hjortoe, G. M., Petersen, L. C., Albrektsen, T., Sorensen, B. B., Norby, P. L., Mandal, S. K., Pendurthi, U. R., & Rao, L. V. M. (2004) · Blood · doi:10.1182/blood-2003-10-3417 · Cited by 268
The thrombomodulin–protein C system is essential for the maintenance of pregnancy
Isermann, B., Sood, R., Pawlinski, R., Zogg, M., Kalloway, S., Degen, J. L., Mackman, N., & Weiler, H. (2003) · Nature Medicine · doi:10.1038/nm825 · Cited by 263
Activated protein C: biased for translation
Griffin, J. H., Zlokovic, B. V., & Mosnier, L. O. (2015) · Blood · doi:10.1182/blood-2015-02-355974 · Cited by 257
Endotoxins and Other Sepsis Triggers
Opal, S. M. (2010) · Contributions to Nephrology · doi:10.1159/000315915 · Cited by 256
Lyons, J. J., Chovanec, J., O’Connell, M. P., Liu, Y., Šelb, J., Zanotti, R., Bai, Y., Kim, J., Le, Q. T., DiMaggio, T., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.06.035 · Cited by 230
Endothelial cell protein C receptor: a multiliganded and multifunctional receptor
Mohan Rao, L. V., Esmon, C. T., & Pendurthi, U. R. (2014) · Blood · doi:10.1182/blood-2014-05-578328 · Cited by 203
Zhong, Z., Ilieva, H., Hallagan, L., Bell, R., Singh, I., Paquette, N., Thiyagarajan, M., Deane, R., Fernandez, J. A., Lane, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38476 · Cited by 176
Uchiba, M., Okajima, K., Oike, Y., Ito, Y., Fukudome, K., Isobe, H., & Suda, T. (2004) · Circulation Research · doi:10.1161/01.res.0000133680.87668.fa · Cited by 162
Cytoprotective protein C pathways and implications for stroke and neurological disorders
Zlokovic, B. V., & Griffin, J. H. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.01.005 · Cited by 128
Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells
Yang, X. V., Banerjee, Y., Fernández, J. A., Deguchi, H., Xu, X., Mosnier, L. O., Urbanus, R. T., de Groot, P. G., White-Adams, T. C., McCarty, O. J. T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807594106 · Cited by 116
Protease-activated receptors in health and disease
Peach, C. J., Edgington-Mitchell, L. E., Bunnett, N. W., & Schmidt, B. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00044.2021 · Cited by 116
Thiyagarajan, M., Fernández, J. A., Lane, S. M., Griffin, J. H., & Zlokovic, B. V. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3485-08.2008 · Cited by 105
“To determine whether tPA or APC treatment produced microhemorrhages in brain tissue, we used a spectrophotometric hemoglobin assay, as we reported previously (Shibata et al., 2001; Cheng et al., 2006).”
BackgroundMethodResultInfluentialActivated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function
Minhas, N., Xue, M., Fukudome, K., & Jackson, C. J. (2010) · The FASEB Journal · doi:10.1096/fj.09-134445 · Cited by 94
Jeon, M.-T., Kim, K.-S., Kim, E. S., Lee, S., Kim, J., Hoe, H.-S., & Kim, D.-G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101333 · Cited by 76
Slofstra, S. H., Bijlsma, M. F., Groot, A. P., Reitsma, P. H., Lindhout, T., ten Cate, H., & Spek, C. A. (2007) · Blood · doi:10.1182/blood-2007-02-075440 · Cited by 66
Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?
Debreczeni, M. L., Németh, Z., Kajdácsi, E., Farkas, H., & Cervenak, L. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08851-8 · Cited by 25
Metadata
- Authors
- Riewald, M., Petrovan, R. J., Donner, A., Mueller, B. M., & Ruf, W.
- Venue
- Science
- Published
- 2002-06-07
- Volume
- 296
- Issue
- 5574
- Pages
- 1880-1882
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2000985786
- Cited by
- 831
- References
- 22
- FWCI
- 24.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.